Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP-daclizumab in ATLL
NCT01418430Phase 4Completed
- Sponsor
- King's College Hospital
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of daclizumab in adult T-cell leukemia-lymphoma (ATLL), sponsored by King's College Hospital. Status: completed.
02
Drugs
daclizumab
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on NCT01418430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01418430.